Alan Young
Employees
Sustainable Resource Engineering
France
Biography
Alan Young is a pharmacologist who has worked in respiratory research for over 25 years, exclusively within the pharmaceutical industry. Prior to Charles River, he was both Discovery Director for early development and Head of Respiratory Disease Sciences at AstraZeneca, where he was responsible for progressing compounds into Phase IIB clinical studies. In these roles, he led multiple respiratory-based projects, and delivered more than 20 candidate drugs into clinical development. He later became the Business Development Manager for Argenta, an IDD CRO acquired by Charles River in 2014. Dr. Young’s honors include the Edgar Allen Fellowship from the University of Sheffield. His research has resulted in over 200 peer-reviewed papers and presentations.
Research Interest
Respiratory and Inflammation
